Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PSMD14 pseudogene 1 (PSMD14P1) is a pseudogene corresponding to the PSMD14 gene, which encodes a component of the 26S proteasome complex involved in ubiquitin-mediated protein degradation. PSMD14P1 itself does not encode a functional protein and does not serve as a therapeutic or druggable target. A pseudogene for PSMD14 is annotated on the long arm of chromosome 2 and does not participate in proteasomal or cellular processes[1][5]. The functional, druggable target is the protein-coding gene PSMD14, also known as 26S proteasome non-ATPase regulatory subunit 14, Rpn11, POH1, or PAD1[3][7]. PSMD14 plays essential roles in protein degradation, oncogenesis, DNA damage response, and is actively being pursued as a therapeutic target in cancer and related diseases[1][4][6]. In contrast, PSMD14P1 refers to the pseudogene and should not be considered as an active molecular target for therapy or mechanistic studies. There is therefore something wrong with this target name if used in the context of functional targets: PSMD14P1 is a pseudogene, not a receptor, enzyme, transporter, or druggable protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PSMD14 pseudogene 1 (PSMD14P1).